Methyl aminolevulinate (MAL) and hexaminolevulinate (HAL) [hexyl aminolevulinate] photodynamic therapy (PDT) [photochemotherapy] of cervical intraepithelial lesions (SIL) - a double-blind dose-finding study

Trial Profile

Methyl aminolevulinate (MAL) and hexaminolevulinate (HAL) [hexyl aminolevulinate] photodynamic therapy (PDT) [photochemotherapy] of cervical intraepithelial lesions (SIL) - a double-blind dose-finding study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 Sep 2015

At a glance

  • Drugs Hexyl aminolevulinate (Primary) ; Methyl aminolevulinate (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Sponsors PhotoCure
  • Most Recent Events

    • 29 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top